Abingworth raises Europe’s biggest biotech fund

Abingworth, the UK life sciences VC house, has raised Europe’s largest ever venture fund dedicated to life sciences. Abingworth Bioventures V (ABV V) has €455m at its disposal, well over the target size of €380m.

1 March 2007•2 mins read
Feature image
LinkedInXEmail
LinkedInXEmail